GovWire

Research: ENG1 and ML5 annual medical reports and summaries

Maritime Coastguard Agency

February 13
12:49 2025

class="gem-c-govspeak govuk-govspeak gem-c-govspeak--direction-ltr govuk-!-margin-bottom-0">

Every year the returns of all the seafarer medical examinations carried out by MCA approved doctors (ADs), and their outcomes, are summarised in annual reports and summaries.

The chief medical advisor uses these reports to audit and consider the ADs reappointment for the coming year.

Click here for the ML5 Annual Report for 2022.

Click here for the ML5 Annual Report for 2023.

Updates to this page

Published 6 May 2014
Last updated 13 February 2025 +show all updates
  1. Adding 2023 ENG1 annual report.

  2. Added links to the 2022 and 2023 ML5 reports

  3. Annual Stats report for 2022 added.

  4. Updated to include the ML5 annual report 2021.

  5. Updated with the ENG1 annual medical report and summary 2021.

  6. Updated to include the ML5 annual report 2020.

  7. Updated with the annual medical reports for 2018 and 2019.

  8. Updated with the annual ENG1 medical report and statistical summary for 2020.

  9. Updated with the annual ENG1 medical report and statistical summary for 2019.

  10. Updated to include the ENG1 annual medical report and summary 2018.

  11. Updated to include the ML5 Annual Medical Report 2017

  12. Updated with the ENG1 Annual medical report 2016

  13. Updated with the latest ENG1 annual medical report and summary 2017.

  14. Updated ENG1 annual medical report and summary 2016

  15. ML5 annual medical report 2015 uploaded

  16. 2015 report and summaries added to attachments

  17. ML5 annual medical report for 2014 added 26 August 2015

  18. Annual summaries of seafarer's medical examinations by approved doctors from 2005 to 2009 added.

  19. ENG1 annual medical report and summary 2014 added

  20. ML5 Annual medical report 2013 added 10 september 2014

  21. 2013 Annual Medical Report and Summary added 30/06/14

  22. First published.

Sign up for emails or print this page

Related Articles

Comments

  1. We don't have any comments for this article yet. Why not join in and start a discussion.

Write a Comment

Your name:
Your email:
Comments:

Post my comment

Recent Comments

Follow Us on Twitter

Share This


Enjoyed this? Why not share it with others if you've found it useful by using one of the tools below: